{"changes":[],"country":"US","description":"Triveni Bio develops RNA medicines for cardiovascular and metabolic diseases, focusing on targets validated by human genetics. Its platform selects natural RNA mechanisms—antisense, siRNA, or saRNA—based on what each biology requires rather than applying a single modality to every program.","domain":"trivenibio.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"biotech|immunology|therapeutics","investors":[],"lat":42.365258,"lng":-71.184323,"location":"Watertown MA","name":"Triveni Bio","rounds":[{"amountQuarantined":false,"amountUsd":115000000,"currency":"USD","date":"2024-09-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"series-b","url":null}],"slug":"trivenibio-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"trivenibio.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://trivenibio.com"},{"fact":"description","publisher":"trivenibio.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://trivenibio.com"}],"stage":"series-b+","techStack":["Google Cloud CDN","OpenResty","Google Cloud","Nginx"],"totalRaisedUsd":115000000,"updatedAt":"2026-05-07"}